Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5 activity. by Graaf, S.F.J. van de et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/51365
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Fast Track
Identification of BSPRY as a Novel Auxiliary Protein
Inhibiting TRPV5 Activity
Stan F.J. van de Graaf, Annemiete W.C.M. van der Kemp, Dennis van den Berg,
Mijke van Oorschot, Joost G.J. Hoenderop, and Rene´ J.M. Bindels
Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands
Transient receptor potential vallinoid 5 (TRPV5) and TRPV6 are the most Ca2-selective members of the TRP superfamily and
are essential for active Ca2 (re)absorption in epithelia. However, little is known about intracellular proteins that regulate the
activity of these channels. This study identified BSPRY (B-box and SPRY-domain containing protein) as a novel factor
involved in the control of TRPV5. The interaction between BSPRY and TRPV5 by GST pull-down and co-immunoprecipi-
tation assays was demonstrated. BSPRY showed co-localization with TRPV5 in mouse kidney. Expression of BSPRY resulted
in a significant reduction of the Ca2 influx in Madin-Darby Canine Kidney cells that stably express TRPV5 without affecting
channel cell-surface abundance. Finally, BSPRY expression in kidney was increased in 25-hydroxyvitamin D3-1-hydroxylase
knockout mice, suggesting an inverse regulation by vitamin D3. Together, these results demonstrate the physiologic role of the
novel protein BSPRY in the regulation of epithelial Ca2 transport via negative modulation of TRPV5 activity.
J Am Soc Nephrol 17: 26–30, 2006. doi: 10.1681/ASN.2005101025
T he epithelial Ca
2 channels transient receptor potential
vallinoid 5 (TRPV5) and TRPV6 form two highly Ca2-
permeable members of the TRP superfamily of cation
channels. Recent studies using TRPV5 knockout mice have dem-
onstrated the pivotal gatekeeper role of TRPV5 in active Ca2
reabsorption (1). These mice show a robust renal Ca2 loss and
display considerable bone abnormalities. In addition, TRPV5
knockout mice exhibit a significant Ca2 hyperabsorption, associ-
ated with an increased duodenal TRPV6 expression level, result-
ing from elevated 1,25-dihydroxyvitamin D3 levels (1,2). The pre-
liminary characterization of TRPV6 knockout mice showed
decreased intestinal Ca2 absorption and bone mineral density,
further substantiating the role of this channel in intestinal Ca2
absorption (3). Together, TRPV5 and TRPV6 form the gatekeepers
of transcellular Ca2 transport, and understanding their regula-
tion is pivotal for our insight into the (patho)physiology of Ca2
homeostasis (4). However, the molecular mechanisms underlying
channel trafficking and regulation of its activity at the plasma
membrane are incompletely understood.
The aim of this study, therefore, was to identify proteins that
modulate the activity of TRPV5 or TRPV6 to regulate transcel-
lular Ca2 transport. Here, we describe the identification of
BSPRY (B-box and SPRY-domain containing protein), a novel
protein with previously unknown function, as a channel-asso-
ciated regulatory protein of the epithelial Ca2 channel TRPV5.
Materials and Methods
DNA Constructs and cRNA Synthesis
Full-length BSPRY was obtained from mouse expressed sequence tag
(EST) I.M.A.G.E. 5116439, cloned into the pTLN oocyte expression
vector (5) in frame with an amino-terminal VSV tag and subcloned into
pGEX6p2 (Amersham Biosciences, Uppsala, Sweden) and pCB7 (6).
Full-length and carboxyl-termini of TRPV5 and TRPV6 were obtained
as described previously (7).
Yeast Two-Hybrid System
Y153 yeast strain transformation and subsequently screening of a
mouse kidney cDNA library (Clontech, Palo Alto, CA) was performed
as described previously (7).
Protein–Protein Interaction Assays
Glutathione S-transferase (GST) fusion proteins were expressed in
Escherichia coli BL21 and purified according to the manufacturer’s pro-
tocol (Amersham Biosciences). BSPRY cRNA was synthesized in vitro
using SP6 RNA polymerase as described previously (7) and injected
into Xenopus laevis oocytes. After 2 d, oocytes were lysed in PBS that
contained 0.4% (vol/vol) Triton X-100. [35S]Methionine-labeled full-
length TRPV5/TRPV6 protein was prepared using a reticulocyte lysate
system. Xenopus oocyte lysates or in vitro–translated proteins were
incubated with GST or GST-fusion proteins that were immobilized on
glutathione-Sepharose 4B beads (Amersham Biosciences) in PBS that
contained 0.4% (vol/vol) Triton X-100 for 2 h at room temperature, and
bound proteins were visualized by autoradiography or immunoblot-
ting. MDCK cells that were stably transfected with green fluorescent
protein (GFP)-fused TRPV5 and VSV-BSPRY were lysed in sucrose
buffer that fused contained 20 mM Tris (pH 7.4), 5 mM EDTA, 135 mM
NaCl, 0.5% (vol/vol) NP-40, 0.2% (vol/vol) Triton X-100, and 10%
(wt/vol) sucrose, incubated on ice for 60 min, and centrifuged for 30
min at 16,000  g. Supernatants were incubated with guinea pig anti-
TRPV5 or monoclonal anti-VSV antibodies (Sigma, St. Louis, MO)
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immobilized on protein A-agarose beads (Kem-En-Tec A/S, Copenha-
gen, Denmark) for 16 h at 4°C. Immunoprecipitated proteins were
analyzed by immunoblot analysis.
Reverse Transcription–PCR Analysis
Total RNA was isolated using TRIzol (Life Technologies/BRL, Life
Technologies, Breda, The Netherlands). Total RNA (2 g) was sub-
jected to reverse transcription (RT) using Moloney murine leukemia
virus reverse transcriptase, and a PCR for BSPRY was performed using
the primers 5-GATTCGGAGAAATTAAGC-3 and 5-GGCTGCAGT-
TACAGAGTGC-3. BSPRY mRNA expression was quantified by real-
time PCR using SYBRGreen dye and shown as relative expression to
mouse hypoxanthine-guanine phosphoribosyl transferase (detected
with the forward primer 5-TTATCAGACTGAAGAGCTACTGTAAT-
GATC-3, reverse primer 5-TTACCAGTGTCAATTATATCTTCAA-
CAATC-3), which was used as an endogenous control to normalize
variations in RNA extractions, the degree of RNA degradation, and
variabilities in RT efficiencies. The primers that were used to amplify
-actin were 5-ACCATTTCCCTCTCAGCTGTG-3 and 5-GTATGC-
CTCTGGTCGTACCAC-3.
Preparation of Antibodies and Immunohistochemistry
Rabbit anti-BSPRY antibodies were raised against the peptide H2N-
LFPVFAVADQLISIV-COOH of mouse BSPRY and used for immuno-
histochemistry as described. For semiquantitative determination of
protein levels, images were analyzed with Image J (http://rsb.info.nih.
gov/ij/), resulting in quantification of the protein levels as the mean of
integrated optical density as described (2). All negative controls, in-
cluding preimmune serum and serum depleted of anti-BSPRY antibod-
ies by incubation for 16 h with GST-BSPRY immobilized on glutathi-
one-Sepharose 4B beads, were devoid of staining.
45Ca2 Uptake Assay
Ca2 uptake was determined using MDCK cells by incubation in
uptake medium that contained 1.0 mM CaCl2 for 5 min at room
temperature as described previously.
Cell-Surface Biotinylation
Proteins that were present at the cell surface of confluent stably
transfected MDCK cells were biotinylated at 4°C using NHS-LC-LC-
biotin (0.5 mg/ml; Pierce, Etten-Leur, The Netherlands), precipitated
using neutravidin-coupled beads (Pierce), and analyzed by immuno-
blot analyses.
Statistical Analyses
In all experiments, the data are expressed as mean  SEM. Overall
statistical significance was determined by ANOVA. P  0.05 was
considered significant.
Results and Discussion
Our study provides the first evidence of the physiologic role
of BSPRY as a negative modulator of the epithelial Ca2 chan-
nel TRPV5. This conclusion is based on four independent ob-
servations. First, the specific interaction between this channel
and BSPRY was demonstrated by yeast two-hybrid, GST pull-
down and co-immunoprecipitation assays. Second, BSPRY
showed complete co-localization with TRPV5 in Ca2-trans-
porting tubular segments of the kidney. Third, stable expres-
sion of BSPRY significantly inhibited Ca2 influx in confluent
layers of MDCK cells expressing TRPV5. Fourth, BSPRY ex-
pression was inversely regulated by the calciotropic hormone
vitamin D3.
Identification of BSPRY as a Novel TRPV5- and TRPV6-
Associated Protein
To discover novel TRPV5- and TRPV6-associated proteins, we
performed a yeast two-hybrid screen on a mouse kidney cDNA
library. Using the mouse TRPV6 carboxyl-terminus as bait, five
clones that were identified as BSPRY were isolated. BSPRY con-
tains a B-box and SPRY domain, whose tentative functions are
protein–protein interaction modules (8,9). The association of full-
length BSPRY with GST-TRPV5 or TRPV6 carboxyl-termini, im-
mobilized on Sepharose 4B beads, confirmed the yeast two-hybrid
results and showed that TRPV5 (Figure 1A) also interacts with
BSPRY (Figure 1A). Furthermore, the reverse approach, whereby
full-length, GST-fused BSPRY was immobilized on Sepharose
beads and incubated with in vitro–translated full-length TRPV5 or
TRPV6, resulted in significant binding of both Ca2 channels to
BSPRY (Figure 1B). The binding of BSPRY was equal in the pres-
ence of 1 mM Ca2 or in Ca2-free (2 mM EDTA) conditions,
demonstrating a Ca2-independent association (data not shown).
No interaction was observed with GST alone, indicating the spec-
ificity of the binding.
To substantiate further the BSPRY interaction, we generated
MDCK cell lines that were stably transfected with GFP-fused
TRPV5 and subsequently with VSV-BSPRY or the empty pCB7
vector. These cell lines allowed the investigation of TRPV5 in a
polarized epithelium, whereas endogenous expression levels of
these channels in native tissues, including kidney, were below
the detection limit of immunoblot analysis. Furthermore, these
polarized cells exhibit apical uptake of Ca2 and provide a
valuable model to study TRPV5-mediated Ca2 influx (10).
Using these stably transfected cells, TRPV5 could be co-immu-
noprecipitated with anti-VSV antibodies upon expression of
VSV-BSPRY, as indicated by the specific bands at approxi-
mately 95 kD for the core-glycosylated GFP-TRPV5 and ap-
proximately 115 kD for complex-glycosylated GFP-TRPV5 (Fig-
ure 1C). TRPV5 was not detected in the immunoprecipitated
sample in the absence of VSV-BSPRY, confirming the specificity
of the procedure. Similarly, BSPRY was co-immunoprecipitated
with TRPV5 in the reverse reaction using anti-TRPV5 antibod-
ies that were immobilized on Sepharose beads, as represented
by an immunopositive band of approximately 65 kD (Figure
1D). Here, -actin was used as a control to demonstrate equal
input of the samples. -Actin was absent in the immunopre-
cipitated sample, indicating the specificity of the interaction.
Co-Localization of BSPRY and TRPV5
The expression of BSPRY in mouse tissues was analyzed by
RT-PCR. BSPRY was detected in several tissues, including kid-
ney, small intestine, prostate, lung, and uterus. BSPRY was less
abundantly expressed in heart, whereas skeletal muscle and
liver were negative (Figure 2A, top). All samples expressed
-actin, which was used as a positive control to confirm cDNA
integrity (Figure 2A, bottom). Using anti-BSPRY antibodies,
raised in rabbits using a conserved 15–amino acid peptide of
the carboxyl-terminus of mouse BSPRY, we demonstrated that
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the localization of BSPRY in kidney is strikingly similar to the
localization of TRPV5 (Figure 2B, bottom). BSPRY was present
in the apical domain of all TRPV5-immunopositive tubules,
previously identified as the second part of the distal convoluted
tubule and connecting tubule (11,12). Proximal tubules and
glomeruli were negative, and preimmune serum did not show
any staining. Furthermore, immunopositive BSPRY staining
was absent upon incubation of the serum with immobilized
GST-BSPRY, whereas incubation with GST alone had no effect
(Figure 2B, top). Similar co-localization with TRPV5 in distal
convoluted tubule and connecting tubule was observed previ-
ously for calbindin-D28K and the Na
/Ca2 exchanger (12,13).
These proteins play an essential role in renal transcellular Ca2
transport as they respectively facilitate the diffusion of Ca2
from the apical to the basolateral side and the extrusion into the
blood. Similarly, the robust co-localization between BSPRY and
TRPV5 strongly supports a physiologic and specific function of
BSPRY in the regulation of epithelial Ca2 transport by direct
association with TRPV5 in the kidney.
Figure 1. Interaction of transient receptor potential vallinoid 5
(TRPV5) or TRPV6with BSPRY (B-box and SPRY-domain containing
protein) as shown by glutathione S-transferase (GST) pull-down and
co-immunoprecipitation analyses. (A) Lysates of Xenopus laevis oo-
cytes thatwere injectedwith 10ngofVSV-taggedBSPRYcRNAwere
incubatedwithGST orGST fused to the carboxyl-terminus of TRPV5
or TRPV6 immobilized on glutathione-Sepharose 4B beads. BSPRY
interacted specifically with TRPV5 and TRPV6 but not with GST
alone. (B) [35S]Methionine-labeled full-length TRPV5 or TRPV6 was
incubated with GST or GST-BSPRY immobilized on glutathione-
Sepharose 4B beads. Both TRPV5 andTRPV6 interactedwith BSPRY,
whereas no binding toGST alonewas observed. (C)MDCK cells that
stably expressed green fluorescent protein (GFP)-fused TRPV5 were
transfected with pCB7-VSV-BSPRY of the empty pCB7 vector, and
five clones with equal growth rate and TRPV5 expression of both
conditions were pooled to eliminate clonal variation. MDCK lysates
were incubated with anti-VSV antibodies. Co-immunoprecipitated
TRPV5 was demonstrated using anti-GFP antibodies. TRPV5 could
not be precipitated in the absence of BSPRY (right), although TRPV5
expression was similar in both conditions (left), demonstrating the
specificity of the interaction. (D) Expression of VSV-BSPRY was de-
termined by immunoblot analysis using monoclonal anti-VSV. Ex-
pression of -actin was used to show equal loading. Lysates were
subjected to immunoprecipitation using anti-TRPV5 antibodies. Co-
immunoprecipitatedBSPRYwasdemonstrated by immunoblot anal-
ysis using anti-VSV antibodies. -Actin was not co-immunoprecipi-
tated, showing the specificity of the interaction. None-transfected
MDCK cells (NT) were used to demonstrate the specificity of the
antibodies.
Figure 2. Localization and tissue distribution of BSPRY. (A) RNA
was extracted from several mouse tissues, and BSPRY expression
was determined by reverse transcription–PCR. The BSPRY-spe-
cific bandwas amplified in brain, lung, duodenum, ileum, kidney,
prostate, and uterus (top). A faint signal was detected in heart,
whereas skeletal muscle and liver were negative (top). -Actin
was used as a control to ensure cDNA integrity and was positive
in all tested tissues (bottom). (B) Immunohistochemical analysis of
BSPRY and TRPV5 in mouse kidney sections. To verify the spec-
ificity of the BSPRY antibody, we incubated polyclonal rabbit
BSPRY antiserum for 16 h with GST-BSPRY, immobilized on
glutathione-Sepharose 4B beads. Depletion of the BSPRY antibod-
ies abolished all immunopositive signal, whereas incubation with
immobilized GST alone (not depleted) did not affect the reactivity
of the antiserum. Furthermore, kidney sections were co-stained
with antibodies against BSPRY and TRPV5. BSPRY and TRPV5
have a remarkable similarity in localization and show significant
overlap in the apical region of the cell. No signal was detected
with preimmune serum or with fluorophore-conjugated antibod-
ies only.
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BSPRY-Mediated TRPV5 Inhibition of Ca2 Influx
The effect of BSPRY co-expression on TRPV5-mediated Ca2 in-
flux was measured using confluent monolayers of MDCK cells.
TRPV5 expression in these cells resulted in an approximately 2.5-fold
increased Ca2 influx compared with nontransfected cells. Upon
co-expression with BSPRY, Ca2 influx was inhibited by 41  13%
(Figure 3C), approaching levels of nontransfected cells. Total cellular
TRPV5 expression levels were identical in the presence or absence of
BSPRY, as was demonstrated by immunoblot analysis using anti-
GFP antibodies (Figure 3, A and B). Furthermore, the correct size of
the bands at approximately 95 to 115 kD in Figure 3A confirmed the
integrity of the GFP-TRPV5 fusion protein. Finally, flow cytometry
analysis of the GFP signal showed that 98% of the MDCK cells
forming the confluent monolayer contributed to the TRPV5-depen-
dent Ca2 influx, both in the presence and in the absence of BSPRY
(data not shown). These data provide the first evidence of a func-
tional role of BSPRY. So far, only two studies have provided infor-
mation about BSPRY. First, BSPRY was identified recently in a yeast
two-hybrid screen using zyxin as bait. In epithelial cells, zyxin is
involved in the formation of cell–cell contacts, which require actin
cytoskeleton rearrangements (14). Schenker et al. (15) provided no
data about the localization and function of BSPRY. However, the
association with zyxin might hint at a role of the cytoskeleton in the
BSPRY-mediated regulation of TRPV5. Second, it was shown that
BSPRY interacts with 14-3-3 proteins. Although the exact role of
14-3-3 proteins remains to be elucidated fully, their role in the recog-
nition of phosphorylated proteins is well established (16). It has been
demonstrated that 14-3-3 proteins bind to specific motifs that contain
a phosphorylated serine residue and have been implicated in the
binding to and activation of signaling proteins (16,17). Furthermore, a
role of 14-3-3 proteins in K channel trafficking was postulated (18).
However, cell-surface biotinylation did not provide evidence for
TRPV5 trafficking as an explanation for the observed inhibitory func-
tion of BSPRY (Figure 3D). Furthermore, we demonstrated that a
significant fraction of BSPRY is membrane associated and present at
the plasma membrane (Figure 3, E and F, Supplemental Figure).
Therefore, it is tempting to speculate that BSPRY is involved in
inhibitory signaling cascades that control the activity of the epithelial
Ca2 channels at the cell surface.
Vitamin D–Dependent Regulation of BSPRY Expression
in Kidney
It was demonstrated previously that TRPV5 expression is strongly
regulated by 1,25-dihydroxyvitamin D3, the biologic active form of
vitamin D (4,19). Therefore, we assessed the expression of BSPRY
in wild-type and 25-hydroxyvitamin D3-1-hydroxylase (1-
OHase) knockout mice. These knockout mice are unable to syn-
Figure 3. BSPRY operates as a negative modulator of TRPV5
activity. (A) The expression level of GFP-tagged TRPV5 in
stably transfected MDCK cells was determined by immunoblot
using anti-GFP antibodies and shows equal expression levels in
the presence or absence of BSPRY. (B) BSPRY expression was
verified using monoclonal anti-VSV antibodies. (C) TRPV5 ac-
tivity was determined by radioactive Ca2 uptake in MDCK
cells that were grown to confluence, demonstrating a signifi-
cant inhibition of TRPV5-mediated Ca2 influx upon BSPRY
co-expression. (D) Intact GFP-TRPV5–expressing MDCK cells,
stably transfected with pCB7-VSV-BSPRY or the empty pCB7
vector, were incubated with NHS-LC-LC-biotin to label cell-
surface proteins. Biotinylated proteins were isolated using neu-
travidin-agarose beads, separated by SDS-PAGE, and TRPV5
was subsequently quantified by immunoblot analysis. TRPV5
plasma membrane abundance was equal in the presence or
absence of BSPRY. TRPV5 and BSPRY were not detected in
precipitates from cells that were not exposed to biotin, showing
the specificity of the precipitation for biotinylated proteins.
Similarly, BSPRY was detected in the plasma membrane by
biotinylation (E) and immunocytochemistry (F, arrowheads)
using anti-VSV antibodies on stably BSPRY-transfected MDCK
cells. -Actin was found in the lysate from the biotinylated
MDCK monolayers but not in the fraction recovered from the
neutravidin beads, demonstrating that intracellular proteins are
not isolated using this procedure (data not shown). *P  0.05
versus all. (G) The role of vitamin D3 on BSPRY expression was
determined by quantitative real-time PCR in kidneys of wild-type
(WT; n  11) or 25-hydroxyvitamin D3-1-hydroxylase (1-OHase)
knockout (KO; n  6) mice. (H) Effect of vitamin D3 on BSPRY
protein abundance inmouse kidney. Representative images showing
kidney sections stained for BSPRY in WT or 1-OHase KO mice.
Protein abundance was determined by computerized analysis of
immunohistochemical images and is presented as mean optical den-
sity (arbitrary units) for n 24 to 30 pictures from five mice for each
condition. *P  0.05 versusWT.
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thesize 1,25-dihydroxyvitamin D3 and are a valuable animal
model to study vitamin D deficiency rickets type I (20). Quantita-
tive real-time PCR showed significantly enhanced BSPRY mRNA
expression in the 1-OHase knockout mice compared with wild-
type mice, suggesting that vitamin D negatively regulates the
BSPRY expression (Figure 3G). Because the antibodies that we
generated did not recognize BSPRY on immunoblot, the protein
expression of BSPRY in these animals was semiquantified by
immunohistochemistry. Depicted in Figure 3H are representative
images of BSPRY expression inwild-type and 1-OHase knockout
mice. Computerized analysis of the immunohistochemical stain-
ing showed significantly enhanced BSPRY protein expression in
the 1-OHase knockout mice compared with wild-type mice,
confirming the inverse regulation of BSPRY expression by circu-
lating vitamin D on the protein level (Figure 3H). Together with
the Ca2 uptake results, this suggests that BSPRY operates as a
negative modulator for TRPV5 and that this mechanism will be
downregulated when vitamin D levels increase to stimulate active
Ca2 transport. These findings demonstrate a novel target for
vitamin D3 in the regulation of active Ca
2 transport and provide
new insight into the factors involved in the Ca2-related (patho-
)physiology.
Conclusion
We have identified BSPRY as a novel auxiliary protein of the
epithelial Ca2 channels. The association, co-localization, and
functional analyses described in this study demonstrate the
first physiologic role of the novel protein BSPRY in the direct
regulation of TRPV5.
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